These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 15573100)

  • 1. Development of TGF-beta signalling inhibitors for cancer therapy.
    Yingling JM; Blanchard KL; Sawyer JS
    Nat Rev Drug Discov; 2004 Dec; 3(12):1011-22. PubMed ID: 15573100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TGFbeta-mediated processes in cancer.
    Romano MF
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
    Korpal M; Kang Y
    Eur J Cancer; 2010 May; 46(7):1232-40. PubMed ID: 20307969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
    Akhurst RJ
    Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF beta signalling and its role in tumour pathogenesis.
    Kaminska B; Wesolowska A; Danilkiewicz M
    Acta Biochim Pol; 2005; 52(2):329-37. PubMed ID: 15990918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models.
    Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.
    Perrot CY; Javelaud D; Mauviel A
    Pharmacol Ther; 2013 Feb; 137(2):183-99. PubMed ID: 23063491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 and disorders of the lung.
    Camoretti-Mercado B; Solway J
    Cell Biochem Biophys; 2005; 43(1):131-48. PubMed ID: 16043890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
    White AW; Westwell AD; Brahemi G
    Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Smad TGF-beta signals.
    Moustakas A; Heldin CH
    J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta signaling in vascular fibrosis.
    Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
    Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TGFβ signaling and its implications in anticancer treatments.
    Calone I; Souchelnytskyi S
    Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HtrA proteins as targets in therapy of cancer and other diseases.
    Zurawa-Janicka D; Skorko-Glonek J; Lipinska B
    Expert Opin Ther Targets; 2010 Jul; 14(7):665-79. PubMed ID: 20469960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
    Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Hedgehog pathway in cancer.
    Rubin LL; de Sauvage FJ
    Nat Rev Drug Discov; 2006 Dec; 5(12):1026-33. PubMed ID: 17139287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.